Title : SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis.

Pub. Date : 2014 Nov

PMID : 24947350






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. Exenatide glucagon-like peptide 1 receptor Mus musculus
2 Here, we speculate that SIRT1 might mediate the effect of the GLP-1 receptor agonist exenatide (exendin-4) on ameliorating hepatic steatosis. Exenatide glucagon-like peptide 1 receptor Mus musculus
3 Here, we speculate that SIRT1 might mediate the effect of the GLP-1 receptor agonist exenatide (exendin-4) on ameliorating hepatic steatosis. Exenatide glucagon-like peptide 1 receptor Mus musculus
4 Our data demonstrate that SIRT1 mediates the effect of exenatide on ameliorating hepatic steatosis, suggesting the GLP-1 receptor agonist could serve as a potential drug for nonalcoholic fatty liver disease (NAFLD), especially in type 2 diabetes combined with NAFLD, and SIRT1 could be a therapeutic target of NAFLD. Exenatide glucagon-like peptide 1 receptor Mus musculus